Compare · ETN vs MLAB
ETN vs MLAB
Side-by-side comparison of Eaton Corporation PLC (ETN) and Mesa Laboratories Inc. (MLAB): market cap, price performance, sector, and recent activity on the wire.
Summary
- ETN operates in Technology, while MLAB operates in Industrials - the two are in different parts of the market.
- ETN is the larger of the two at $163.56B, about 283.6x MLAB ($576.7M).
- ETN has been more active in the news (6 items in the past 4 weeks vs 4 for MLAB).
- ETN has more recent analyst coverage (25 ratings vs 3 for MLAB).
- Company
- Eaton Corporation PLC
- Mesa Laboratories Inc.
- Price
- $421.33+0.86%
- $104.21-2.36%
- Market cap
- $163.56B
- $576.7M
- 1M return
- -
- +1.21%
- 1Y return
- -
- +3.96%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 6
- 4
- Recent ratings
- 25
- 3
Eaton Corporation PLC
Eaton Corporation plc operates as a power management company. Its Electrical Americas and Electrical Global segment provides electrical components, industrial components, power distribution and assemblies, residential products, single and three phase power quality products, wiring devices, circuit protection products, utility power distribution products, power reliability equipment, and services in North and South America, as well as hazardous duty electrical, emergency lighting, fire detection, explosion-proof instrumentation, and structural support systems internationally. The company's Hydraulics segment provides pumps, motors, and hydraulic power units; valves, cylinders, and electronic controls; industrial and hydraulic hoses, fittings, assemblies, thermoplastic hose and tubing products, couplings, connectors, and assembly equipment; and industrial drums and disc brakes. Its Aerospace segment offers pumps, motors, hydraulic power units, hoses and fittings, and electro-hydraulic pumps; valves, cylinders, electronic controls, electromechanical actuators, sensors, aircraft flap and slat systems, and nose wheel steering systems; thermoplastic tubing products, fittings, adapters, couplings, and sealing and ducting products; fuel pumps, sensors, valves, and adapters and regulators; and wiring connectors and cables, as well as hydraulic and bag filters, strainers and cartridges, and golf grips. The company's Vehicle segment offers transmissions, clutches, hybrid power systems, superchargers, engine valves and valve actuation systems, cylinder heads, locking and limited slip differentials, transmission controls, and fuel vapor components for the vehicle industry. Its eMobility segment provides voltage inverters, converters, fuses, onboard chargers, circuit protection units, vehicle controls, power distribution systems, fuel tank isolation valves, and commercial vehicle hybrid systems. The company was founded in 1916 and is based in Dublin, Ireland.
Mesa Laboratories Inc.
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The company's Instruments segment designs, manufactures, and markets quality control hardware and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. This segment's products include dialysate meters and calibration solutions, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company's Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Continuous Monitoring segment designs, develops, and markets systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Latest ETN
- SEC Form SD filed by Eaton Corporation PLC
- Director Thompson Dorothy C sold $64,295 worth of Ordinary Shares (167 units at $385.00), decreasing direct ownership by 13% to 1,096 units (SEC Form 4)
- Officer Galvao Antonio sold $200,492 worth of Ordinary Shares (494 units at $405.86), decreasing direct ownership by 5% to 9,175 units (SEC Form 4)
- Director Johnson Gerald bought $390,197 worth of Ordinary Shares (961 units at $406.03), increasing direct ownership by 144% to 1,629 units (SEC Form 4)
- CORRECTION - Leverage Shares by Themes Targets Market Movers Across Tech and Industrials with Nine New 2X Single-Stock ETFs
- Leverage Shares by Themes Targets Market Movers Across Tech and Industrials with Nine New 2X Single-Stock ETFs
- Director Page Gregory R converted options into 621 units of Ordinary Shares and covered exercise/tax liability with 150 units of Ordinary Shares, increasing direct ownership by 1% to 44,090 units (SEC Form 4)
- Director Napoli Silvio converted options into 621 units of Ordinary Shares and covered exercise/tax liability with 299 units of Ordinary Shares, increasing direct ownership by 22% to 1,756 units (SEC Form 4)
- Officer Monesmith Heath B. sold $7,514,074 worth of Ordinary Shares (18,367 units at $409.11), decreasing direct ownership by 27% to 49,822 units (SEC Form 4)
- Director Johnson Gerald converted options into 353 units of Ordinary Shares and covered exercise/tax liability with 85 units of Ordinary Shares, increasing direct ownership by 67% to 668 units (SEC Form 4)
Latest MLAB
- SEC Form S-8 filed by Mesa Laboratories Inc.
- Mesa Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results
- Amendment: SEC Form 4 filed by President and CEO Kadia Siddhartha
- Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026
- SEC Form 4 filed by President and CEO Kadia Siddhartha
- SEC Form 3 filed by new insider Kadia Siddhartha
- MESA LABS DECLARES QUARTERLY DIVIDEND
- SEC Form 4 filed by Owens Gary M
- Amendment: SEC Form SCHEDULE 13G/A filed by Mesa Laboratories Inc.